Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial

Peer Review reports

Original Submission
29 Nov 2016	Submitted	Original manuscript
22 Dec 2016	Reviewed	Reviewer Report - Marco Merli
26 Jan 2017	Reviewed	Reviewer Report - David R Snydman
5 Feb 2017	Author responded	Author comments - Pinyo Rattanaumpawan
Resubmission - Version 2
5 Feb 2017	Submitted	Manuscript version 2
10 Feb 2017	Author responded	Author comments - Pinyo Rattanaumpawan
Resubmission - Version 3
10 Feb 2017	Submitted	Manuscript version 3
Publishing
22 Feb 2017	Editorially accepted
1 Mar 2017	Article published	10.1186/s12879-017-2284-1

Back to article page